[1]谷世英,朱雷,徐海亮,等.脊髓损伤后免疫调节策略研究进展[J].陕西医学杂志,2025,54(9):1285-1290.[doi:DOI:10.3969/j.issn.1000-7377.2025.09.024]
 GU Shiying,ZHU Lei,XU Hailiang,et al.Research progress on immune regulation strategies after spinal cord injury[J].,2025,54(9):1285-1290.[doi:DOI:10.3969/j.issn.1000-7377.2025.09.024]
点击复制

脊髓损伤后免疫调节策略研究进展

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
54
期数:
2025年9期
页码:
1285-1290
栏目:
综 述
出版日期:
2025-09-05

文章信息/Info

Title:
Research progress on immune regulation strategies after spinal cord injury
作者:
谷世英12朱雷3徐海亮3白胶胶4罗振国2
(1.陕西中医药大学第二临床医学院,陕西 咸阳 712046;2.西安交通大学附属红会医院麻醉科,陕西 西安 710054;3.西安交通大学附属红会医院脊柱外科,陕西 西安 710054;4.西安交通大学附属红会医院护理部,陕西 西安 710054)
Author(s):
GU Shiying12ZHU Lei3XU Hailiang3BAI Jiaojiao4LUO Zhenguo2
(1.The Second Clinical Medical College of Shaanxi University of Chinese Medicine,Xianyang 712046,China;2.Department of Anesthesiology,Honghui Hospital Affiliated to Xi’an Jiaotong University,Xi’an 710054,China;3.Department of Spine Surgery,Honghui Hospital Affiliated to Xi’an Jiaotong University,Xi’an 710054,China;4.Nursing Department,Honghui Hospital Affiliated to Xi’an Jiaotong University,Xi’an 710054,China)
关键词:
脊髓损伤免疫调节动态演变时空异质性临床转化分子机制
Keywords:
KEY WORDSSpinal cord injuryImmune regulationDynamic evolutionSpatiotemporal heterogeneityClinical translationMolecular mechanism
分类号:
R 651.2
DOI:
DOI:10.3969/j.issn.1000-7377.2025.09.024
文献标志码:
A
摘要:
脊髓损伤(SCI)后,免疫反应在神经功能修复与恢复过程中扮演关键调控角色。干细胞移植、生物材料驱动的局部免疫重塑以及药物-免疫协同治疗等免疫调节策略均对神经功能恢复具有一定的作用,但同时也面临诸多挑战。现对SCI后免疫反应从急性期到慢性期的动态演变过程进行阐述,并剖析各阶段关键免疫细胞、因子及相互作用机制,探讨免疫调控的核心靶点与新兴策略,分析当前临床转化面临的挑战,为深入理解SCI免疫机制及开发精准免疫调控疗法提供理论依据与参考。
Abstract:
The immune response following spinal cord injury (SCI) plays a complex and critical dual role in nerve repair and functional recovery.Immune modulation strategies such as stem cell transplantation,local immune remodeling driven by biomaterials,and drug-immune combination therapy all have certain effects on the recovery of neurological function,but they also face many challenges.The dynamic evolution process of the immune response after SCI from the acute phase to the chronic phase is elaborated,and the key immune cells,factors and interaction mechanisms at each stage are analyzed,and the core targets and emerging strategies of immune regulation are discussed,and the challenges faced in current clinical translation are analyzed,in order to provide theoretical basis and reference for a deeper understanding of the immune mechanism of SCI and the development of precise immune regulation therapies.

参考文献/References:

[1]HU X,XU W,REN Y,et al.Spinal cord injury:Molecular mechanisms and therapeutic interventions[J].Signal Transduct Target Ther,2023,8(1):245.
[2]WANG S,LI G,LIANG X,et al.Small extracellular vesicles derived from altered peptide ligand-loaded dendritic cell act as a therapeutic vaccine for spinal cord injury through eliciting CD4+T cell-mediated neuroprotective immunity[J].Adv Sci (Weinh),2024,11(3):e2304648.
[3]ZHOU H Y,WANG X,LI Y,et al.Dynamic development of microglia and macrophages after spinal cord injury[J].Neural Regen Res,2025,20(12):3606-3619.
[4]YU H,FAN P,DENG X,et al.Nerve-derived extracellular matrix promotes neural differentiation of bone marrow stromal cells and enhances interleukin-4 efficacy for advanced nerve regeneration[J].Adv Healthc Mater,2025,14(7):e2402713.
[5]GAO Y,WANG K,WU Y,et al.Controlled release of MIF siRNA and GDNF protein from a photocurable scaffold efficiently repairs spinal cord injury[J].Med Comm (2020),2025,6(3):e70099.
[6]ZHANG W,LIU M,REN J,et al.Magnetic nanoparticles and methylprednisolone based physico-chemical bifunctional neural stem cells delivery system for spinal cord injury repair[J].Adv Sci (Weinh),2024,11(21):e2308993.
[7]XUE X,WU X,FAN Y,et al.Heterogeneous fibroblasts contribute to fibrotic scar formation after spinal cord injury in mice and monkeys[J].Nat Commun,2024,15(1):6321.
[8]TIAN Z,HU H J,CHAN C C,et al.Self-healing COCu-Tac hydrogel enhances inscs transplantation for spinal cord injury by promoting mitophagy via the FKBP52/AKT pathway[J].Adv Sci (Weinh),2025,12(3):e2407757.
[9]KUMAR H,JO M J,CHOI H,et al.Matrix metalloproteinase-8 inhibition prevents disruption of blood-spinal cord barrier and attenuates inflammation in rat model of spinal cord injury[J].Mol Neurobiol,2018,55(3):2577-2590.
[10]KUMAR H,CHOI H,JO M J,et al.Neutrophil elastase inhibition effectively rescued angiopoietin-1 decrease and inhibits glial scar after spinal cord injury[J].Acta Neuropathol Commun,2018,6(1):73.
[11]CASILI G,IMPELLIZZERI D,CORDARO M,et al.B-cell depletion with CD20 antibodies as new approach in the treatment of inflammatory and immunological events associated with spinal cord injury[J].Neurotherapeutics,2016,13(4):880-894.
[12]JAMANN H,CUI Q L,DESU H L,et al.Contact-dependent granzyme B-mediated cytotoxicity of Th17-polarized cells toward human oligodendrocytes[J].Front Immunol,2022,13:850616.
[13]ANKENY D P,LUCIN K M,SANDERS V M,et al.Spinal cord injury triggers systemic autoimmunity:Evidence for chronic B lymphocyte activation and lupus-like autoantibody synthesis[J].J Neurochem,2006,99(4):1073-1087.
[14]KONG F Q,ZHAO S J,SUN P,et al.Macrophage MSR1 promotes the formation of foamy macrophage and neuronal apoptosis after spinal cord injury[J].J Neuroinflammation,2020,17(1):62.
[15]VAN BROECKHOVEN J,SOMMER D,DOOLEY D,et al.Macrophage phagocytosis after spinal cord injury:When friends become foes[J].Brain,2021,144(10):2933-2945.
[16]GONG L,GU Y,HAN X,et al.Spatiotemporal dynamics of the molecular expression pattern and intercellular interactions in the glial scar response to spinal cord injury[J].Neurosci Bull,2023,39(2):213-244.
[17]王恺,张赛,陈旭义,等.十二井穴针刺对脊髓损伤大鼠脊髓功能恢复及转化生长因子β/smad通路的影响[J].中国医药,2018,13(11):1742-1745.
[18]ZHANG Y,XIAO S,DAN F,et al.Phillygenin inhibits neuroinflammation and promotes functional recovery after spinal cord injury via TLR4 inhibition of the NF-kappaB signaling pathway[J].J Orthop Translat,2024,48:133-145.
[19]HU X,HUANG J,LI Z,et al.Lactate promotes microglial scar formation and facilitates locomotor function recovery by enhancing histone H4 lysine 12 lactylation after spinal cord injury[J].J Neuroinflammation,2024,21(1):193.
[20]BRETHEAU F,CASTELLANOS-MOLINA A,BELANGER D,et al.The alarmin interleukin-1alpha triggers secondary degeneration through reactive astrocytes and endothelium after spinal cord injury[J].Nat Commun,2022,13(1):5786.
[21]LENTILHAS-GRACA J,SANTOS D J,AFONSO J,et al.The secretome of macrophages has a differential impact on spinal cord injury recovery according to the polarization protocol[J].Front Immunol,2024,15:1354479.
[22]GUO J,TANG X,DENG P,et al.Interleukin-4 from curcumin-activated OECs emerges as a central modulator for increasing m2 polarization of microglia/macrophage in OEC anti-inflammatory activity for functional repair of spinal cord injury[J].Cell Commun Signal,2024,22(1):162.
[23]CUI J,XU H,YU J,et al.Targeted depletion of PD-1-expressing cells induces immune tolerance through peripheral clonal deletion[J].Sci Immunol,2024,9(94):eadh0085.
[24]GAO W,KIM M W,DYKSTRA T,et al.Engineered T cell therapy for central nervous system injury[J].Nature,2024,634(8034):693-701.
[25]ASSINCK P,DUNCAN G J,HILTON B J,et al.Cell transplantation therapy for spinal cord injury[J].Nat Neurosci,2017,20(5):637-647.
[26]ORAEE-YAZDANI S,AKHLAGHPASAND M,GOLMOHAMMADI M,et al.Combining cell therapy with human autologous schwann cell and bone marrow-derived mesenchymal stem cell in patients with subacute complete spinal cord injury:Safety considerations and possible outcomes[J].Stem Cell Res Ther,2021,12(1):445.
[27]BYDON M,QU W,MOINUDDIN F M,et al.Author correction:Intrathecal delivery of adipose-derived mesenchymal stem cells in traumatic spinal cord injury:Phase Ⅰ trial[J].Nat Commun,2024,15(1):4799.
[28]唐剑,陈双华,何凌.骨髓间充质干细胞来源外泌体对大鼠脊髓损伤的改善作用及对脊髓组织胞浆型磷脂酶A2、水通道蛋白4和水通道蛋白9的影响实验研究[J].陕西医学杂志,2023,52(12):1654-1659.
[29]MARTIN J R,CLEARY D,ABRAHAM M E,et al.Long-term clinical and safety outcomes from a single-site phase 1 study of neural stem cell transplantation for chronic thoracic spinal cord injury[J].Cell Rep Med,2024,5(12):101841.
[30]PANG X,ZHANG T,LI J,et al.LDH nanoparticles-doped cellulose nanofiber scaffolds with aligned microchannels direct high-efficiency neural regeneration and organized neural circuit remodeling through RHoA/Rock/Myosin Ⅱ pathway[J].Biomaterials,2025,314:122873.
[31]CHEN W,ZHANG Y,YANG S,et al.Neuroregen scaffolds combined with autologous bone marrow mononuclear cells for the repair of acute complete spinal cord injury:A 3-year clinical study[J].Cell Transplant,2020,29:963689720950637.
[32]TANG F,TANG J,ZHAO Y,et al.Long-term clinical observation of patients with acute and chronic complete spinal cord injury after transplantation of neuroregen scaffold[J].Sci China Life Sci,2022,65(5):909-926.
[33]MAYNARD G,KANNAN R,LIU J,et al.Soluble nogo-receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA:A first-in-human and randomised clinical trial[J].Lancet Neurol,2023,22(8):672-684.
[34]BOURGUIGNON L,LUKAS L P,KONDILES B R,et al.Impact of commonly administered drugs on the progression of spinal cord injury:A systematic review[J].Commun Med (Lond),2024,4(1):213.
[35]LV Y,LI Z,JIAN H,et al.CX3CL1-mediated neuronal “rescue signal” influences inflammation progression following spinal cord injury via microglia[J].Int Immunopharmacol,2025,153:114478.
[36]SKINNIDER M A,GAUTIER M,TEO A Y Y,et al.Single-cell and spatial atlases of spinal cord injury in the tabulae paralytica[J].Nature,2024,631(8019):150-163.
[37]LIU Z,YANG Y,HE L,et al.High-dose methylprednisolone for acute traumatic spinal cord injury:A meta-analysis[J].Neurology,2019,93(9):e841-e850.
[38]MANESH A,GAUTAM P,KUMAR D S,et al.Effectiveness of adjunctive high-dose infliximab therapy to improve disability-free survival among patients with severe central nervous system tuberculosis:A matched retrospective cohort study[J].Clin Infect Dis,2023,77(10):1460-1467.

相似文献/References:

[1]宋 丹,孙欣荣.模式识别受体的免疫调节作为限制流感策略研究进展[J].陕西医学杂志,2019,(3):401.
[2]宋海峰,张庭继,于正刚,等.腰椎间盘突出症合并有下尿路症状患者临床与尿动力学研究*[J].陕西医学杂志,2019,(12):1608.
 SONG Haifeng,ZHANG Tingji,YU Zhenggang,et al.Clinical and urodynamic analysis on protrusion of lumbar intervertebral disc patients with urinary voiding dysfunction[J].,2019,(9):1608.
[3]段科科,刘时璋△.S100β蛋白与脊髓损伤相关性研究进展*[J].陕西医学杂志,2020,49(6):766.[doi:DOI:10.3969/j.issn.10007377.2020.06.032]
[4]贺世集,高 枫.姜黄素治疗脊髓损伤后相关信号通路研究进展[J].陕西医学杂志,2021,50(1):123.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.032]
[5]崔 佳,刘敏丽.乙酰左旋肉碱对脊髓损伤后线粒体的保护作用研究进展[J].陕西医学杂志,2021,50(3):374.[doi:DOI:10.3969/j.issn.1000-7377.2021.03.031]
 CUI Jia,LIU Minli.Protective effect of acetyl L-carnitine on mitochondria after spinal cord injury[J].,2021,50(9):374.[doi:DOI:10.3969/j.issn.1000-7377.2021.03.031]
[6]唐 剑,陈双华,何 凌.骨髓间充质干细胞来源外泌体对大鼠脊髓损伤的改善作用及对脊髓组织胞浆型磷脂酶A2、水通道蛋白4和水通道蛋白9的影响实验研究[J].陕西医学杂志,2023,52(12):1654.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.006]
 TANG Jian,CHEN Shuanghua,HE Ling.Improvement effects of BMSCs-derived exosomes on spinal cord injury in rats and its effects on cytosolic phospholipase A2,aquaporin 4 and aquaporin 9 in spinal cord tissues[J].,2023,52(9):1654.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.006]
[7]田 飞,赵晨光,胡 旭,等.脊髓损伤患者全身炎症综合指数与深静脉血栓形成相关性研究[J].陕西医学杂志,2025,54(4):475.[doi:DOI:10.3969/j.issn.1000-7377.2025.04.008]
 TIAN Fei,ZHAO Chenguang,HU Xu,et al.Correlation between aggregate index of systemic inflammation and deep vein thrombosis in patients with spinal cord injury[J].,2025,54(9):475.[doi:DOI:10.3969/j.issn.1000-7377.2025.04.008]
[8]孙明阳,刘 海,齐曼曼,等.高压氧调控JAK2/STAT3通路对小鼠脊髓损伤的影响实验研究[J].陕西医学杂志,2025,54(5):612.[doi:DOI:10.3969/j.issn.1000-7377.2025.05.007]
 SUN Mingyang,LIU Hai,QI Manman,et al.Effects of hyperbaric oxygen on spinal cord injury in mice via regulation of the JAK2/STAT3 pathway[J].,2025,54(9):612.[doi:DOI:10.3969/j.issn.1000-7377.2025.05.007]
[9]宋光烨,叶春伟,袁顺辉,等.脊髓损伤并发尿路感染患者血清IP-10、DcR3水平变化及检测意义[J].陕西医学杂志,2025,54(5):678.[doi:DOI:10.3969/j.issn.1000-7377.2025.05.021]
 SONG Guangye,YE Chunwei,YUAN Shunhui,et al.Changes and detection significance of serum IP-10 and DcR3 levels in patients with spinal cord injury complicated by urinary tract infection[J].,2025,54(9):678.[doi:DOI:10.3969/j.issn.1000-7377.2025.05.021]
[10]邱少彬,罗红群,邱菲,等.三七注射液通过抑制增殖细胞核抗原表达及调控辅助性T细胞1型/2型平衡改善MRL-Faslpr狼疮肾炎小鼠肾损伤的机制研究[J].陕西医学杂志,2025,54(7):888.[doi:DOI:10.3969/j.issn.1000-7377.2025.07.004]
 QIU Shaobin,LUO Hongqun,QIU Fei,et al.Mechanism of sanqi injection in ameliorating renal injury in MRL-Faslpr lupus nephritis micevia suppressing PCNA expression and regulating Th1/Th2 balance[J].,2025,54(9):888.[doi:DOI:10.3969/j.issn.1000-7377.2025.07.004]

备注/Memo

备注/Memo:
国家自然科学基金资助项目(82171379);西安市科技计划项目(22YXYJ0019)
更新日期/Last Update: 2025-09-04